REGADENOSON and LOSS OF CONSCIOUSNESS

181 reports of this reaction

2.1% of all REGADENOSON reports

#14 most reported adverse reaction

Overview

LOSS OF CONSCIOUSNESS is the #14 most commonly reported adverse reaction for REGADENOSON, manufactured by Astellas Pharma US, Inc.. There are 181 FDA adverse event reports linking REGADENOSON to LOSS OF CONSCIOUSNESS. This represents approximately 2.1% of all 8,610 adverse event reports for this drug.

REGADENOSON has an overall safety score of 78 out of 100. Patients taking REGADENOSON who experience loss of consciousness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

LOSS OF CONSCIOUSNESS181 of 8,610 reports

LOSS OF CONSCIOUSNESS is a less commonly reported adverse event for REGADENOSON, but still significant enough to appear in the safety profile.

Other Side Effects of REGADENOSON

In addition to loss of consciousness, the following adverse reactions have been reported for REGADENOSON:

NAUSEA — 509 reports
DYSPNOEA — 408 reports
INJECTION SITE EXTRAVASATION — 361 reports
VOMITING — 357 reports
HEADACHE — 315 reports
HYPOTENSION — 312 reports
CARDIAC ARREST — 283 reports
DIZZINESS — 272 reports
SEIZURE — 251 reports
CHEST PAIN — 230 reports

Other Drugs Associated with LOSS OF CONSCIOUSNESS

The following drugs have also been linked to loss of consciousness in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ETHYL ALCOHOL EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL LIDOCAINE HCL PAIN RELIEF PHENOBARBITAL SODIUM Trelegy TRIAZOLAM

Frequently Asked Questions

Does REGADENOSON cause LOSS OF CONSCIOUSNESS?

LOSS OF CONSCIOUSNESS has been reported as an adverse event in 181 FDA reports for REGADENOSON. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is LOSS OF CONSCIOUSNESS with REGADENOSON?

LOSS OF CONSCIOUSNESS accounts for approximately 2.1% of all adverse event reports for REGADENOSON, making it a notable side effect.

What should I do if I experience LOSS OF CONSCIOUSNESS while taking REGADENOSON?

If you experience loss of consciousness while taking REGADENOSON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

REGADENOSON Full Profile All Drugs Causing LOSS OF CONSCIOUSNESS Astellas Pharma US, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.